from Reuters: Health News http://ift.tt/2C3BBF8 February 17, 2018 at 02:26AM
Saturday, 17 February 2018
AstraZeneca's immunotherapy drug wins key lung cancer approval
LONDON (Reuters) - AstraZeneca's immunotherapy drug Imfinzi has won crucial approval from U.S. regulators for use in lung cancer, opening up a multibillion-dollar market for a medicine that has so far lagged behind competitors.
from Reuters: Health News http://ift.tt/2C3BBF8 February 17, 2018 at 02:26AM
from Reuters: Health News http://ift.tt/2C3BBF8 February 17, 2018 at 02:26AM
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment